MedTrace Logo

Prolactin and FGF21 in Gestational Diabetes Mellitus

NCT05528393 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-09-06

No results posted yet for this study

Summary

Prolactin (PRL) and PRL receptor (PRLR) signaling has been validated to play an important role in the modulation of glucolipid metabolism. However, the role of serum PRL levels in gestational diabetes mellitus (GDM) remains unclear. The investigators aimed to explore the possible influence of serum PRL within or without normal range on the development of GDM.

Conditions

  • Gestational Diabetes Mellitus in Pregnancy
  • Hyperprolactinemia Pregnancy

Interventions

DIAGNOSTIC_TEST

Blood sampling

blood sampling

Sponsors & Collaborators

  • Shen Qu

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2022-09-01
Completion
2022-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05528393 on ClinicalTrials.gov